BACKGROUND: Substituting galactose for glucose in cell culture media has been suggested to enhance mitochondrial metabolism in a variety of cell lines. We studied the effects of carbohydrate availability on growth, differentiation and metabolism of C2C12 myoblasts and myotubes. METHODOLOGY/PRINCIPAL FINDINGS: We measured growth rates, ability to differentiate, citrate synthase and respiratory chain activities and several parameters of mitochondrial respiration in C2C12 cells grown in media with varying carbohydrate availability (5 g/l glucose, 1 g/l glucose, 1 g/l galactose, and no added carbohydrates). C2C12 myoblasts grow more slowly without glucose irrespective of the presence of galactose, which is not consumed by the cells, and they fail to differentiate without glucose in the medium. Cells grown in a no-glucose medium (with or without galactose) have lower maximal respiration and spare respiratory capacity than cells grown in the presence of glucose. However, increasing glucose concentration above physiological levels decreases the achievable maximal respiration. C2C12 myotubes differentiated at a high glucose concentration showed higher dependency on oxidative respiration under basal conditions but had lower maximal and spare respiratory capacity when compared to cells differentiated under low glucose condition. Citrate synthase activity or mitochondrial yield were not significantly affected by changes in the available substrate concentration but a trend towards a higher respiratory chain activity was observed at reduced glucose levels. CONCLUSIONS/SIGNIFICANCE: Our results show that using galactose to increase oxidative metabolism may not be applicable to every cell line, and the changes in mitochondrial respiratory parameters associated with treating cells with galactose are mainly due to glucose deprivation. Moderate concentrations of glucose (1 g/l) in a growth medium are optimal for mitochondrial respiration in C2C12 cell line while supraphysiological concentrations of glucose cause mitochondrial dysfunction in C2C12 myoblasts and myotubes.

Laboratory for Metabolism and Bioenergetics 3rd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Spargo E, Pratt OE, Daniel PM (1979) Metabolic functions of skeletal muscles of man, mammals, birds and fishes: a review. Journal of the Royal Society of Medicine 72: 921–925. PubMed PMC

Sinacore DR, Gulve EA (1993) The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Physical Therapy 73: 878–891. PubMed

Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. PNAS 104: 12587–12594. PubMed PMC

Phielix E, Mensink M (2008) Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiology & Behavior 94: 252–258. PubMed

Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725–727. PubMed

Blau H, Chiu CP, Webster C (1983) Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32: 1171–1180. PubMed

Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, et al. (2004) C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. European Journal of Histochemistry 48: 223–233. PubMed

Ibsen KH (1961) The Crabtree effect: a review. Cancer Research 21: 829–841. PubMed

Marroquin LD, Hynes J, Dykens Ja, Jamieson JD, Will Y (2007) Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicological Sciences 97: 539–547. PubMed

Resnick O, Hechter O (1957) Studies on the permeability of galactose in muscle cells of the isolated rat diaphragm. Journal of Biological Chemistry 224: 941–954. PubMed

Heidenreich R, Mallee J, Rogers S, Segal S (1993) Developmental and tissue-specific modulation of rat galactose-1-phosphate uridyltransferase steady state messenger RNA and specific activity levels. Pediatric Research 34: 416–419. PubMed

Mailloux RJ, Harper ME (2010) Glucose regulates enzymatic sources of mitochondrial NADPH in skeletal muscle cells; a novel role for glucose-6-phosphate dehydrogenase. FASEB J 24: 2495–2506. PubMed

Aguer C, Gambarotta D, Mailloux RJ, Moffat C, Dent R, et al. (2011) Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PloS One 6: e28536. PubMed PMC

Brown D, Parr T, Brameld J (2012) Myosin heavy chain mRNA isoforms are expressed in two distinct cohorts during C2C12 myogenesis. Journal of Muscle Research and Cell Motility 32: 383–390. PubMed

Fulco M, Cen Y, Zhao P, Hoffman EP, Mcburney MW, et al. (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Developmental Cell 14: 661–673. PubMed PMC

Nedachi T, Kadotani A, Ariga M, Katagiri H, Kanzaki M (2008) Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. American Journal of Physiology Endocrinology and Metabolism 294: 668–678. PubMed

Holloszy OJ, Oscai BL, Don JI, Mole AP (1970) Mitochondrial citric acid cycle and related enzymes: Adaptive response to excercise. Biochemical and Biophysical Research Communications 40: 1368–1373. PubMed

Williams RS, Salmons S, Newsholme EA, Kaufman RE, Mellor J (1986) Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. Journal of Biological Chemistry 261: 376–380. PubMed

Hood AD, Zak R, Pette D (1989) Chronic stimulation of rat skeletal muscle induces coordinate increases in mitochondrial and nuclear mRNAs of cytochrome-c-oxidase subunits. European Journal of Biochemistry 179: 275–280. PubMed

Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, et al. (2004) Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Research 64: 985–993. PubMed

Palmfeldt J, Vang Sr, Stenbroen V, Pedersen CB, Christensen JH, et al. (2009) Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress. Proteome Science 7: 20. PubMed PMC

Leary SC, Battersby BJ, Hansford RG, Moyes CD (1998) Interactions between bioenergetics and mitochondrial biogenesis. Biochimica et Biophysica Acta 1365: 522–530. PubMed

Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochemical Journal 435: 297–312. PubMed PMC

Miyake T, McDermott JC, Gramolini AO (2011) A method for the direct identification of differentiating muscle cells by a uorescent mitochondrial dye. PloS One 6: e28628. PubMed PMC

Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. American Journal of Physiology Cell physiology 292: 125–136. PubMed

Janssen A, Trijbels F, Sengers R, Smeitink J, Heuvel L, et al. (2007) Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clinical Chemistry 53: 729–734. PubMed

Luo C, Long J, Liu J (2008) An improved spectrophotometric method for a more specific and accurate assay of mitochondrial complex III activity. Clinica Chimica Acta 395: 38–41. PubMed

Cooperstein SJ, Lazarow A (1951) A microspectrophotometric method for the determination of cytochrome oxidase. The Journal of Biological Chemistry 189: 665–670. PubMed

Gardner M, Altman D (1986) Confidence intervals rather than P values : estimation rather than hypothesis testing. British Medical Journal 292: 746–750. PubMed PMC

Cumming G (2012) The new statistics: effect sizes, confidence intervals and meta-analysis. New York: Routledge.

Optimizing Recovery in Elderly Patients: Anabolic Benefits of Glucose Supplementation during the Rehydration Period

Mitochondrial Probe Methyltriphenylphosphonium (TPMP) Inhibits the Krebs Cycle Enzyme 2-Oxoglutarate Dehydrogenase